More than 75 percent of primary care physicians in the United States who order or perform the fecal occult blood test as a screening option for colorectal cancer perform an in-office test rather than ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...

1. A Single Office-Based Stool Blood Test (FOBT) Is a Poor, but Often Used, Screening Test for Colorectal Cancer Two articles and an editorial in the Jan. 18, 2005, Annals of Internal Medicine discuss ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

Objective: To assess patient preferences for 1 of the recommended colorectal cancer screening options or stool DNA testing (sDNA), a novel noninvasive screening test. Study Design: Cross-sectional ...

Please provide your email address to receive an email when new articles are posted on . Patients who received a positive fecal occult blood test as an initial screening for colorectal cancer may need ...

P<0.05 is of statistical significance. ASA, acetylsalicylic acid; CI, confidence interval; FOBT, fecal occult blood test; g-FOBT, guaiac FOBT; i-FOBT, immunochemical ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool ...

(Reuters Health) - A screening test for colon cancer that looks for "invisible" blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests.

Expensive colonoscopies that cost a patient over $1,000 on average could soon be replaced by simpler and much cheaper tests as non-invasive screening options become more available and more ...

Evaluating the clinical utility of universal screening to identify Lynch syndrome in stage III/III colorectal cancer patients: A prospective observational study in Japan. ACPS Stage RFS/PFS Hazard ...